Clinical Trials Directory

Trials / Unknown

UnknownNCT00584350

Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
330 (estimated)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal is to determine if prehydration based on LEVDP is superior to a standard hydratation with NaCl 0.9% or NaHCO3 for the prevention of contrast nephropathy related to a diagnostic coronary angiogram or to PCI.

Detailed description

The goal is to determine if prehydration based on LEVDP is superior to a standard hydratation, independant of volemic status, with NaCl 0.9% or NaHCO3 for the prevention of contrast nephropathy related to a diagnostic coronary angiogram or to PCI.

Conditions

Interventions

TypeNameDescription
OTHERHydratation according LVEDP + NaHCO3Hydration with bolus of NaCl 0.9 to reach a LVEDP of 18 mmHg or more. This procedure is done while the patient is in the laboratory, with a catheter in the left ventricle. At the same time, an infusion of a sodium bicarbonate solution (150 mEq/L) is started at a rate of 1 ml/kg/h (max 110 ml/h) for 7 hours.
OTHERnormal salinehydratation with normal saline (1 cc/kg/h; max 110 cc/h) starting at 8PM the day before the test and ending at 8PM the day of the test (24 hours total).
OTHERSodium bicarbonatehydratation with sodium bicarbonate (150 mEq/L) at 3 cc/kg/h (max 330 cc/h) for 1 hour before the test and then, to be continued at 1 cc/kg/h (max 110 cc/h) for 6 hours (total of 7 hours of hydratation).

Timeline

Start date
2007-11-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2008-01-02
Last updated
2015-02-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00584350. Inclusion in this directory is not an endorsement.